Last Updated : Thursday, January 16, 2020 14:25:28

News of Pharmaceuticals | Healthcare | Wellness in Gujarat

India’s First New Discovery Antibiotics from WOCKHARDT gets Regulatory nod

MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceuticals company Wockhardt Ltd said of having got Indian Regulatory approval for India’s first new discovery of antibiotics. The press-release titled, “India’s First New Discovery Antibiotics from Wockhardt Granted Indian Regulatory Approval”, enclosed with the regulatory filing as

STRIDES PHARMA gets USFDA nod to market nasal treatment drug

BANGALORE | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Bangalore headquartered Strides Pharma Science Ltd said of having USFDA (US Food and Drugs Administration) nod to market nasal treatment drug – Loratadine OTC Softgel Capsules in 10 mg dosage value. The press-release titled, “Strides receives USFDA approval for Loratadine OTC Softgel Capsules”, enclosed with

ALEMBIC PHARMA gets USFDA nod to market anti-diabetic drug

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara headquartered Indian Pharmaceutical products manufacturing major – Alembic Pharmaceuticals Ltd said of having got tentative approval for marketing anti-diabetic drug – Empagliflozin Tablets in dosages of 10 mg (milligram) and 25 mg, primely aimed to substitute

ALEMBIC PHARMA gets USFDA nod to market anti-spasm drug

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Indian pharmaceutical major – Alembic Pharmaceuticals Ltd said of having got approval to market anti-spasm (muscle contraction) drug. The release titled, “Alembic Pharmaceuticals announces USFDA Final Approval for Tizanidine Hydrochloride Capsules, 2 mg, 4

SUN PHARMA inks pact to commercialize haemoglobin maintenance drug

MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered Indian Pharma Major – Sun Pharmaceuticals Ltd said of having inked licensing agreement with US based Rockwell Medical, for commercializing Triferic, a drug used for iron replacement and haemoglobin maintenance, for treating anaemia in hemodialysis patients in India.

ALEMBIC PHARMA gets USFDA nod to market depressive disorder treatment

VADODARA (BARODA) | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered India pharmaceutical major – Alembic Pharmaceuticals receives USFDA Final Approval for drug Vilazodone Hydrochloride Tablets in 10 mg. 20 mg, and 40 mg dosage, which is used to treat depressive disorder and had a

US Regulators slam 3 observations to LUPIN’s Tarapur facility

MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceuticals sector Indian Major Lupin Ltd said of its Tarapur facility being inspected by US regulators and the inspection has been closed with 3 observation, further the facility being classified under the OAI (Official Action Indicated) category. The filing

MAHINDRA LOGISTICS kicks-off distribution centre in North India

MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mahindra Logistics Ltd – logistics arm of diversified Indian Conglomerate – Mahindra Group, said of having opened state-of-the-art distribution centre in North India primely to cater the logistics requirements of pharma sector. The press-release titled, “Mahindra Logistics opens state-of-art distribution

CABINET nods Healthcare pact inked with GATES FOUNDATION

NEW DELHI | RAJKOT – In a press-release as issued by Press Information Bureau (PIB) of India, press & publicity arm of Indian Government, it read of The Union Cabinet having given approval on the memorandum of co-operation inked between India and Bill & Melinda Gates Foundation, for co-operation in the areas of Health and

GLENMARK PHARMA gets USFDA nod to mkt tablets to treat excess iron

MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Indian Pharmaceutical company Glenmark Pharmaceuticals Ltd said of having got nod from USFDA (US Food and Drugs Administration) to market tablet to treat excess iron in the body, usually such iron overload is created due to blood transfusion in adults

GUJARAT GOV nods infra, healthcare, water-mgmt projects worth 18.88 bln INR

GANDHINAGAR | RAJKOT – In a press-release issued by Information Department of Gujarat, press & publicity arm of Gujarat Government it read that Gujarat Chief Minister Vijay Rupani approved infrastructure, healthcare and water-infra projects including urban infra, healthcare, water infra etc across 6 municipal corporations (urban civic bodies) including Ahmedabad, Vadodara, Surat, Rajkot, Jamnagar and

COMM & IND MINISTRY OF INDIA keen to promote India-Africa Trade

NEW DELHI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a press release disbursed by Press Information Bureau (PIB) – Government of India’s press & publicity arm, it read of Ministry of Commerce & Industries of India was keen to promote India-Africa Trade and economic relations with nations of African Continent. The press-release titled, “Ministry of Commerce

ASTER DM HEALTH acquires Nursing Care company, in Abu Dhabi

KOCHI | MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Kochi (Kerala) headquartered Indian healthcare company – Aster DM Healthcare Ltd said of having acquired nursing care company Wahat Al Aman Home Healthcare LLC in Abu Dhabi on 30th December, 2019 – Monday for cash consideration

ALEMBIC PHARMA gets USFDA nod to market opthalmic treatement

VADODARA (BARODA) | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Vadodara (Baroda) headquartered Indian Pharma company – Alembic Pharmaceuticals Ltd said of having got USFDA (US Food & Drugs Administration) nod to market ophthalmic treatment – Travoprost Opthalmic Solution USP, 0.004%. The approved abbreviated new drug application

JB CHEM clarifies on the confusion around Rantac®(Ranitidine)

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceuticals company JB Chemicals and Pharmaceuticals Ltd clarified on the reports having appeared in some sections of media indicating that their brand Rantac® (Ranitidine molecule) has been banned, which the company said was false and incorrect.

GLENMARK PHARMA gets approval to market nasal-treatment in AUSTRALIA

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered Indian Pharmaceutical company Glenmark Pharmaceuticals Ltd said of having announced approval market medicine – Ryaltris® to treat nasal (nose) related disorders, in Australia. In a press-release as communicated by the company to the Indian Bourses, titled

Do NOT follow this link or you will be banned from the site!